Astec Lifesciences Q2 FY27 Share Price & Earnings Call Analysis

25out of 100

Momentum score · price trend

25 out of 100 — Cooling

Over the past year its share price has done worse than most of the stocks we track.

PeriodShare price changeBetter than … of 1,909 stocks
Last 12 months−2.3%58%
Last 6 months−12.9%36%
Last 3 months−1.8%65%

The price is 69.8% below its all-time high of ₹2,160.78 (28 Oct 2022). Stocks more than 20% below their peak have their score halved, so 51 became 25.

How we calculate it

“Better than 30%” means that over that period the share price did better than 30 out of every 100 stocks we track (1,909 Indian companies worth ₹500 Cr or more, with at least a year of prices).

The score weighs the longer periods more: 40% × 12-month + 40% × 6-month + 20% × 3-month. For Astec Lifescienc: 0.4 × 58 + 0.4 × 36 + 0.2 × 65 = 51, halved to 25 because the price is more than 20% below its all-time high.

Strengthening is 70 and above, Steady 40 to 70, Cooling below 40. Scores are recalculated every night after the market closes.

Full methodology →

This describes only how the share price has moved up to 26 Oct 2026, compared with other stocks. It says nothing about the business, and it is not a prediction, a price target or a recommendation to buy or sell.

Financials of Astec Lifescienc

Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.

Shareholder Pattern

Astec Lifescienc

Shareholding breakup across reporting periods.

Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Promoters +66.75%66.75%66.75%66.74%66.74%70.87%70.87%72.42%71.97%71.97%71.97%71.97%
FIIs +1.28%1.25%1.03%0.53%1.20%0.25%0.02%0.00%0.04%0.03%0.01%0.02%
DIIs +9.74%7.88%3.37%4.50%5.40%4.34%4.26%4.01%3.17%3.33%3.33%3.34%
Public +22.22%24.12%28.85%28.20%26.64%24.53%24.84%23.57%24.82%24.67%24.69%24.67%
No. of Shareholders19,24419,84819,95519,72719,05718,68918,54918,27622,29321,04119,88919,707

Pros & Cons

Astec Lifescienc

Key positives and risks surfaced from the company insights section.

Pros
No explicit positive notes available.
Cons
  • Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 R&D expenditure as percentage of total turnover % of turnover 0.68 Annual Report - 31 Mar 2016 “Total R&D expenditure as a percentage of total turnover 0.52 0.68” Page 103 · Source 0.52 Annual Report - 31 Mar 2016 “Total R&D expenditure as a percentage of total turnover 0.52 0.68” Page 103 · Source 0.47 Annual Report - 31 Mar 2017 “Total R&D expenditure as a percentage of total turnover 0.47 0.54” Page 56 · Source 0.56 Annual Report - 31 Mar 2018 “Total R&D expenditure as a percentage of total turnover 0.56 0.47” Page 71 · Source 0.70 Annual Report - 31 Mar 2019 “Total R&D expenditure as a percentage of total turnover 0.70% 0.56%” Page 70 · Source 2.26 Annual Report - 31 Mar 2020 “Total R&D expenditure as a percentage of total turnover … 2.26% 0.70%” Page 83 · Source 3.97 Annual Report - 31 Mar 2021 “Capital & Recurring 2,200.38 1,177.71 / Total R&D Expenditure as a percentage of Total Turnover 3.97% 2.26%” Page 66 · Source 3.54 Annual Report - 31 Mar 2022 “Total R&D Expenditure as a percentage of Total Turnover 3.54%” Page 146 · Source 12.26 Annual Report - 31 Mar 2023 “Total R&D Expenditure as a Percentage of Total Turnover … 12.26% … 3.54%” Page 91 · Source 10.88 Annual Report - 31 Mar 2024 “Total R&D Expenditure as a Percentage of Total Turnover … 10.88% … 12.26%” Page 73 · Source 7.30 Annual Report - 31 Mar 2025 “Total R&D Expenditure as a Percentage of Total Turnover … 7.30% … 10.88%” Page 79 · Source 4.87 Annual Report - 31 Mar 2026 “Total R&D Expenditure as a Percentage of Total Turnover” Page 76 · Source Export share of total revenue % of revenue 50.00 Annual Report - 31 Mar 2016 “exports currently contribute to ~50% of the revenues” Page 105 · Source 41.43 Annual Report - 31 Mar 2017 “Sale of products - Export Sales 12,959.17 / Domestic Sales (including excise duty) 17,342.17 / TOTAL 31,275.74” Page 125 · Source 54.60 Annual Report - 31 Mar 2018 “Exports increased from 42.8% of sales to 54.6% of sales” Page 7 · Source 56.60 Annual Report - 31 Mar 2020 “Export 29,541.49 / Domestic 22,680.60 / Total Turnover 52,222.09” Page 30 · Source 50.00 Concall Transcript - 13 Aug 2021 “Domestic is around 60% year-on-year and export is around 40% [growth rates] … blended growth is 11% and the domestic growth is little more” Page 15 · Source 58.00 Annual Report - 31 Mar 2022 “The proportion of exports increased to 58% of the total income” Page 21 · Source 61.00 Annual Report - 31 Mar 2023 “Proportion of exports in total sales increased to 61% in FY 2022-23 from 58% in the previous year” Page 18 · Source 72.00 Annual Report - 31 Mar 2024 “Proportion of exports in total sales … 72%” Page 48 · Source 68.00 Annual Report - 31 Mar 2025 “Proportion of exports in total sales declined to 68% in FY 2024-25 from 72% in the previous year” Page 17 · Source 62.00 Annual Report - 31 Mar 2026 “Geographically, exports constituted 62% and domestic sales 38% of total revenue.” Page 22 · Source Total permanent employees employees 245 Annual Report - 31 Mar 2016 “the number of permanent employees on the rolls of the Company was 245 as on 31st March, 2016” Page 80 · Source 247 Annual Report - 31 Mar 2017 “247 permanent employees as on March 31, 2017” Page 59 · Source 267 Annual Report - 31 Mar 2018 “The total number of permanent employees on the rolls of the Company as on March 31, 2018 is 267” Page 74 · Source 371 Annual Report - 31 Mar 2020 “the number of permanent employees on the rolls of the Company is 371” Page 53 · Source 473 Annual Report - 31 Mar 2021 “The total number of permanent employees on the rolls of your Company as on 31st March, 2021 was 473” Page 52 · Source 506 Annual Report - 31 Mar 2022 “Total number of permanent employees as on 31st March, 2022 … 506” Page 157 · Source 551 Annual Report - 31 Mar 2023 “The total number of permanent employees on the rolls of your Company as on 31st March, 2023 was 551” Page 74 · Source 421 Annual Report - 31 Mar 2024 “Number of Permanent Employees on the rolls of Company as on 31st March, 2024 … 421” Page 61 · Source 597 Annual Report - 31 Mar 2025 “Number of Permanent Employees on the rolls of Company as on 31st March, 2025 597 as on 31st March, 2025” Page 78 · Source 471 Annual Report - 31 Mar 2026 “The total number of permanent employees on the rolls of your Company as on 31st March, 2026 was 471.” Page 63 · Source CDMO/Contract Manufacturing share of total revenue % of revenue 27.00 Credit Rating - 23 Mar 2017 “FY2016: ~73%; 9M FY2017: 63.5% [Enterprise division] – implying CRAMS/Enterprise shares of 27% and 36.5%” Page 2 · Source 36.50 Credit Rating - 23 Mar 2017 “the company's CRAMS division (contract manufacturing sales) reported a robust y-o-y growth of 82% … Enterprise division (non-contract sales) revenues continue to dominate (FY2016: ~73%; 9M FY2017: 63.5%)” Page 2 · Source 20.00 Concall Transcript - 13 Aug 2021 “It is typically 80:20 at the moment – 20% is CMO, last year it was 17%” Page 7 · Source 13.00 Concall Transcript - 10 May 2022 “For the full financial year, our contribution in revenues from the CMO business were close to 13% … last year we were at roughly 17%” Page 13 · Source 26.00 Annual Report - 31 Mar 2023 “Share of CDMO sales increased to 26% in FY 2022-23 from 13% in FY 2021-22” Page 18 · Source 60.00 Annual Report - 31 Mar 2024 “CDMO revenues reached ₹273 Crore in FY 2023-24 with 1.7x growth, taking CDMO share to 60%” Page 47 · Source 54.00 Annual Report - 31 Mar 2025 “Share of CDMO sales decreased to 54% in the F.Y. 2024-25 from 60% in F.Y. 2023-24” Page 51 · Source 52.00 Annual Report - 31 Mar 2026 “CDMO contributed 52% of total sales in FY 2025–26, with Enterprise segment accounting for the remaining 48%.” Page 22 · Source Number of countries exported to countries 24 Annual Report - 31 Mar 2021 “your Company's products are exported to more than 24 (Twenty four) countries” Page 66 · Source 17 Annual Report - 31 Mar 2024 “International (No. of Countries) 17” Page 10 · Source 18 Annual Report - 31 Mar 2025 “Our robust export presence spans across 18 countries worldwide, including the United States of America, Europe, West Asia, Southeast Asia, Latin America and Africa” Page 11 · Source 19 Annual Report - 31 Mar 2026 “sells its products in India as well as exports them to 19 countries, worldwide.” Page 49 · Source R&D Expenditure (Percentage of Turnover) % ・Standalone data 0.68 Annual Report - 31 Mar 2016 Source 0.52 Annual Report - 31 Mar 2016 Source 0.47 Annual Report - 31 Mar 2017 Source 0.56 Annual Report - 31 Mar 2019 Source 0.70 Annual Report - 31 Mar 2019 Source 2.26 Annual Report - 31 Mar 2020 Source 3.97 Annual Report - 31 Mar 2021 Source 3.54 Annual Report - 31 Mar 2023 Source 12.26 Annual Report - 31 Mar 2024 Source 10.88 Annual Report - 31 Mar 2024 Source 7.30 Annual Report - 31 Mar 2026 Source 4.87 Annual Report - 31 Mar 2026 Source
Raw Insights
  • Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 R&D expenditure as percentage of total turnover % of turnover 0.68 Annual Report - 31 Mar 2016 “Total R&D expenditure as a percentage of total turnover 0.52 0.68” Page 103 · Source 0.52 Annual Report - 31 Mar 2016 “Total R&D expenditure as a percentage of total turnover 0.52 0.68” Page 103 · Source 0.47 Annual Report - 31 Mar 2017 “Total R&D expenditure as a percentage of total turnover 0.47 0.54” Page 56 · Source 0.56 Annual Report - 31 Mar 2018 “Total R&D expenditure as a percentage of total turnover 0.56 0.47” Page 71 · Source 0.70 Annual Report - 31 Mar 2019 “Total R&D expenditure as a percentage of total turnover 0.70% 0.56%” Page 70 · Source 2.26 Annual Report - 31 Mar 2020 “Total R&D expenditure as a percentage of total turnover … 2.26% 0.70%” Page 83 · Source 3.97 Annual Report - 31 Mar 2021 “Capital & Recurring 2,200.38 1,177.71 / Total R&D Expenditure as a percentage of Total Turnover 3.97% 2.26%” Page 66 · Source 3.54 Annual Report - 31 Mar 2022 “Total R&D Expenditure as a percentage of Total Turnover 3.54%” Page 146 · Source 12.26 Annual Report - 31 Mar 2023 “Total R&D Expenditure as a Percentage of Total Turnover … 12.26% … 3.54%” Page 91 · Source 10.88 Annual Report - 31 Mar 2024 “Total R&D Expenditure as a Percentage of Total Turnover … 10.88% … 12.26%” Page 73 · Source 7.30 Annual Report - 31 Mar 2025 “Total R&D Expenditure as a Percentage of Total Turnover … 7.30% … 10.88%” Page 79 · Source 4.87 Annual Report - 31 Mar 2026 “Total R&D Expenditure as a Percentage of Total Turnover” Page 76 · Source Export share of total revenue % of revenue 50.00 Annual Report - 31 Mar 2016 “exports currently contribute to ~50% of the revenues” Page 105 · Source 41.43 Annual Report - 31 Mar 2017 “Sale of products - Export Sales 12,959.17 / Domestic Sales (including excise duty) 17,342.17 / TOTAL 31,275.74” Page 125 · Source 54.60 Annual Report - 31 Mar 2018 “Exports increased from 42.8% of sales to 54.6% of sales” Page 7 · Source 56.60 Annual Report - 31 Mar 2020 “Export 29,541.49 / Domestic 22,680.60 / Total Turnover 52,222.09” Page 30 · Source 50.00 Concall Transcript - 13 Aug 2021 “Domestic is around 60% year-on-year and export is around 40% [growth rates] … blended growth is 11% and the domestic growth is little more” Page 15 · Source 58.00 Annual Report - 31 Mar 2022 “The proportion of exports increased to 58% of the total income” Page 21 · Source 61.00 Annual Report - 31 Mar 2023 “Proportion of exports in total sales increased to 61% in FY 2022-23 from 58% in the previous year” Page 18 · Source 72.00 Annual Report - 31 Mar 2024 “Proportion of exports in total sales … 72%” Page 48 · Source 68.00 Annual Report - 31 Mar 2025 “Proportion of exports in total sales declined to 68% in FY 2024-25 from 72% in the previous year” Page 17 · Source 62.00 Annual Report - 31 Mar 2026 “Geographically, exports constituted 62% and domestic sales 38% of total revenue.” Page 22 · Source Total permanent employees employees 245 Annual Report - 31 Mar 2016 “the number of permanent employees on the rolls of the Company was 245 as on 31st March, 2016” Page 80 · Source 247 Annual Report - 31 Mar 2017 “247 permanent employees as on March 31, 2017” Page 59 · Source 267 Annual Report - 31 Mar 2018 “The total number of permanent employees on the rolls of the Company as on March 31, 2018 is 267” Page 74 · Source 371 Annual Report - 31 Mar 2020 “the number of permanent employees on the rolls of the Company is 371” Page 53 · Source 473 Annual Report - 31 Mar 2021 “The total number of permanent employees on the rolls of your Company as on 31st March, 2021 was 473” Page 52 · Source 506 Annual Report - 31 Mar 2022 “Total number of permanent employees as on 31st March, 2022 … 506” Page 157 · Source 551 Annual Report - 31 Mar 2023 “The total number of permanent employees on the rolls of your Company as on 31st March, 2023 was 551” Page 74 · Source 421 Annual Report - 31 Mar 2024 “Number of Permanent Employees on the rolls of Company as on 31st March, 2024 … 421” Page 61 · Source 597 Annual Report - 31 Mar 2025 “Number of Permanent Employees on the rolls of Company as on 31st March, 2025 597 as on 31st March, 2025” Page 78 · Source 471 Annual Report - 31 Mar 2026 “The total number of permanent employees on the rolls of your Company as on 31st March, 2026 was 471.” Page 63 · Source CDMO/Contract Manufacturing share of total revenue % of revenue 27.00 Credit Rating - 23 Mar 2017 “FY2016: ~73%; 9M FY2017: 63.5% [Enterprise division] – implying CRAMS/Enterprise shares of 27% and 36.5%” Page 2 · Source 36.50 Credit Rating - 23 Mar 2017 “the company's CRAMS division (contract manufacturing sales) reported a robust y-o-y growth of 82% … Enterprise division (non-contract sales) revenues continue to dominate (FY2016: ~73%; 9M FY2017: 63.5%)” Page 2 · Source 20.00 Concall Transcript - 13 Aug 2021 “It is typically 80:20 at the moment – 20% is CMO, last year it was 17%” Page 7 · Source 13.00 Concall Transcript - 10 May 2022 “For the full financial year, our contribution in revenues from the CMO business were close to 13% … last year we were at roughly 17%” Page 13 · Source 26.00 Annual Report - 31 Mar 2023 “Share of CDMO sales increased to 26% in FY 2022-23 from 13% in FY 2021-22” Page 18 · Source 60.00 Annual Report - 31 Mar 2024 “CDMO revenues reached ₹273 Crore in FY 2023-24 with 1.7x growth, taking CDMO share to 60%” Page 47 · Source 54.00 Annual Report - 31 Mar 2025 “Share of CDMO sales decreased to 54% in the F.Y. 2024-25 from 60% in F.Y. 2023-24” Page 51 · Source 52.00 Annual Report - 31 Mar 2026 “CDMO contributed 52% of total sales in FY 2025–26, with Enterprise segment accounting for the remaining 48%.” Page 22 · Source Number of countries exported to countries 24 Annual Report - 31 Mar 2021 “your Company's products are exported to more than 24 (Twenty four) countries” Page 66 · Source 17 Annual Report - 31 Mar 2024 “International (No. of Countries) 17” Page 10 · Source 18 Annual Report - 31 Mar 2025 “Our robust export presence spans across 18 countries worldwide, including the United States of America, Europe, West Asia, Southeast Asia, Latin America and Africa” Page 11 · Source 19 Annual Report - 31 Mar 2026 “sells its products in India as well as exports them to 19 countries, worldwide.” Page 49 · Source R&D Expenditure (Percentage of Turnover) % ・Standalone data 0.68 Annual Report - 31 Mar 2016 Source 0.52 Annual Report - 31 Mar 2016 Source 0.47 Annual Report - 31 Mar 2017 Source 0.56 Annual Report - 31 Mar 2019 Source 0.70 Annual Report - 31 Mar 2019 Source 2.26 Annual Report - 31 Mar 2020 Source 3.97 Annual Report - 31 Mar 2021 Source 3.54 Annual Report - 31 Mar 2023 Source 12.26 Annual Report - 31 Mar 2024 Source 10.88 Annual Report - 31 Mar 2024 Source 7.30 Annual Report - 31 Mar 2026 Source 4.87 Annual Report - 31 Mar 2026 Source

Financials of Astec Lifescienc

Quarterly Results

Quarter-by-quarter operating performance

Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Sales +1115115469999412091741251598472
Expenses +11469141116118100114102801211498492
Operating Profit-3-1813-46-20-66-11-749-1-20
OPM %-3.1%-36%8%-67%-20%-6%4.6%-12%-9%3.2%6%-0.8%-27%
Other Income +112122111-1311
Interest6677910101187887
Depreciation9999111112111011121111
Profit before tax-18-32-1-62-39-25-16-33-24-16-8-19-37
Tax %-24%-24%4%-36%0%61%3%0%0%0%-2%-0%-0%
Net Profit +-13-24-1-40-39-40-16-33-24-16-8-19-37
EPS in Rs-6.00-10.86-0.43-17.73-17.21-18.03-7.18-14.75-10.96-7.05-3.48-8.40-16.79

Financials of Astec Lifescienc

Profit & Loss

Annual income statement trend

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales +267233299368431523555677628458381448439
Expenses +213201236299354437443522551464448453446
Operating Profit54326369768511215477-6-66-4-7
OPM %20%14%21%19%18%16%20%23%12%-1.3%-17%-1.0%-1.7%
Other Income +-164-8121112810136633
Interest131312111213592125373530
Depreciation13101415192326343436444545
Profit before tax1312295656618912135-62-141-81-80
Tax %-17%59%33%37%36%23%27%26%27%-24%-4%-0%
Net Profit +15519353648659026-47-135-81-80
EPS in Rs6.662.248.5715.6516.0321.2129.0440.1211.41-20.95-60.16-36.32-35.72
Dividend Payout %16%0%15%8%8%6%5%3%12%0%0%0%

Financials of Astec Lifescienc

Balance Sheet

Capital structure and asset base

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital19192020202020202020202222
Reserves11699119150183227290377400350215368312
Borrowings +9312712712517699187279341494555449330
Other Liabilities +13385691198322618122121911292102129
Total Liabilities362330334413461572678897979975881942794
Fixed Assets +13395103115167194213340318386499459457
CWIP122084219241162312716521201
Investments0000000000000
Other Assets +216215223256275354349534534424361463337
Total Assets362330334413461572678897979975881942794

Financials of Astec Lifescienc

Cash Flows

Operating, investing and financing cash movement

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity +7-13196515168-8247510-8-81
Cash from Investing Activity +-19-17-18-49-52-74-73-104-113-135-15-4
Cash from Financing Activity +1231-1-1837-958180381252494
Net Cash Flow-021-3-0000-0009
Free Cash Flow-13-39-115-37123-111-80-42-125-24-86
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit19%-24%41%116%41%219%13%34%104%-211%20%1,796%

Financials of Astec Lifescienc

Ratios

Working capital efficiency and return ratios

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days14212613512210311212314890135141202
Inventory Days147177133122121131113176268224196169
Days Payable17916911615583218137179161102100107
Cash Conversion Cycle1091341528914225100145197256237263
Working Capital Days19-281-8-28412-17-1-26-56
ROCE %20%12%20%22%20%20%22%22%8%-4%-13%-5%

Continue your research

What Astec Lifescienc's management said in earlier quarters

Others in Fertilizers & Agrochemicals this season

  • Sumitomo Chemical India Ltd (Q2 FY27)

    907 crore, down 2% YoY (Q2FY26 revenue was Rs. Key investor presentation takeaways from Sumitomo Chemical India Ltd's Q2 FY27 investor presentation — and how it

  • Rallis India (Q2 FY27)

    861 Cr. Key investor presentation takeaways from Rallis India's Q2 FY27 investor presentation — and how it ranks against sector peers.

  • Bhagiradha Chemicals & Industries Ltd (Q2 FY26)

    140.1 crore, up 35% YoY from Rs. Key investor presentation takeaways from Bhagiradha Chemicals & Industries Ltd's Q2 FY26 investor presentation — and how it ran

  • Krishana Phosch. (Q2 FY26)

    Trading contributes around 20%–22% of total turnover; trading volumes may vary depending on market conditions. Key concall takeaways from Krishana Phoschem…

Compare:vs Coromandel Intervs F A C Tvs UPL Ltd